Literature DB >> 11156773

Cranial MR imaging of sequelae of prefrontal lobotomy.

A Uchino1, A Kato, T Yuzuriha, Y Takashima, S Kudo.   

Abstract

BACKGROUND AND
PURPOSE: Although prefrontal lobotomy is an obsolete treatment for schizophrenia, we still encounter patients who have undergone this procedure. The purpose of this study was to describe the MR imaging findings of sequelae of prefrontal lobotomy.
METHODS: We retrospectively reviewed cranial MR images of eight patients with schizophrenia who underwent prefrontal lobotomy approximately 50 years previously.
RESULTS: In all patients, a bilateral cavitary lesion with a thick wall was found in the frontal white matter. The genu of the corpus callosum was mildly to markedly atrophic. The size and location of the cavity and the degree of callosal atrophy were correlated.
CONCLUSION: MR imaging is useful for the diagnosis of sequelae of prefrontal lobotomy, including cavitary lesions with dense walls of gliosis and secondary degeneration of the genu of the corpus callosum.

Entities:  

Mesh:

Year:  2001        PMID: 11156773      PMCID: PMC7973933     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  [An autopsy case of glioblastoma occurred in the region after lobotomy].

Authors:  M Ogashiwa; I Muraoka; H Nakano; S Uesugi; T Okuma
Journal:  No To Shinkei       Date:  1990-11

Review 2.  [A case of glioblastoma manifesting 49 years after lobotomy].

Authors:  H Fukushima; T Yamaguchi; T Arai; S Nakagawa; K Tsuchiya; N Torii; M Shirai
Journal:  No To Shinkei       Date:  1998-08

3.  Computerized tomographic sequelae of frontal psychosurgery.

Authors:  J P Dorland; P R Dorland; C Cioloca
Journal:  J Neuroradiol       Date:  1986       Impact factor: 3.447

4.  The computerized tomographic appearance of frontal lobotomy.

Authors:  A W Duncan; W C Schoene; C L Rumbaugh
Journal:  Comput Tomogr       Date:  1980 Oct-Dec

5.  The long-term effects of prefrontal leukotomy.

Authors:  D F Benson; D T Stuss; M A Naeser; W S Weir; E F Kaplan; H L Levine
Journal:  Arch Neurol       Date:  1981-03

6.  Computed tomography after psychosurgery.

Authors:  M Banna; K Adams; E Tunks; M A Finlayson
Journal:  J Comput Assist Tomogr       Date:  1978-01       Impact factor: 1.826

7.  Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus.

Authors:  B Pakkenberg
Journal:  Neuropathol Appl Neurobiol       Date:  1993-10       Impact factor: 8.090

8.  Neurologic outcome of patients with dorsolateral prefrontal leukotomy.

Authors:  B P Karp; D M Juliano; K F Berman; D R Weinberger
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

9.  Leucotomized and nonleucotomized schizophrenics: comparison on tests of attention.

Authors:  D T Stuss; D F Benson; E F Kaplan; W S Weir; C Della Malva
Journal:  Biol Psychiatry       Date:  1981-11       Impact factor: 13.382

10.  Motor abilities after frontal leukotomy.

Authors:  D F Benson; D T Stuss
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

View more
  5 in total

Review 1.  MR imaging of psychosurgery: rostral atrophy following stereotacic subcaudate tractotomy.

Authors:  K A Cauley; W Waheed; M Salmela; C G Filippi
Journal:  Br J Radiol       Date:  2010-11       Impact factor: 3.039

2.  Frontal lobotomy: a vanishing but important radiological finding.

Authors:  Ben Lovell
Journal:  BMJ Case Rep       Date:  2015-08-03

Review 3.  Acquired lesions of the corpus callosum: MR imaging.

Authors:  A Uchino; Y Takase; K Nomiyama; R Egashira; S Kudo
Journal:  Eur Radiol       Date:  2005-11-12       Impact factor: 5.315

4.  Frontal lobotomy.

Authors:  Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2017-02-21       Impact factor: 2.007

5.  Lesion analysis for cingulotomy and limbic leucotomy: comparison and correlation with clinical outcomes.

Authors:  Nikos Makris; Emad N Eskandar; Jimmy C Yang; Daniel T Ginat; Darin D Dougherty
Journal:  J Neurosurg       Date:  2013-11-15       Impact factor: 5.115

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.